Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study

被引：0
|
作者：
Abdullah M. Alguwaihes
机构：
[1] King Saud University,Department of Internal Medicine, College of Medicine
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Dapagliflozin; Diabetic ketoacidosis; HbA1c; Post-authorization safety study; Saudi Arabia; SGLT2 inhibitor; T2DM; Urinary tract infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1979 / 1992
页数：13
相关论文
共 50 条
  • [21] Knowledge of Complications of Diabetes Mellitus among Patients with Type 2 Diabetes in Saudi Arabia: A Descriptive Study
    Hassounah, Ghadeer
    Al Dossari, Huda Joman
    Robert, Asirvatham Alwin
    CURRENT DIABETES REVIEWS, 2023, 19 (05) : 141 - 147
  • [22] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [23] Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
  • [24] Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
    Hinnen, Deborah
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (03) : 92 - 102
  • [25] Incidence of hyperkalemia in patients of type 1 and type 2 diabetes mellitus in Saudi Arabia
    Al-ajlan, Abdul Rahman
    WORLD FAMILY MEDICINE, 2007, 5 (03): : 27 - 29
  • [26] TREATMENT PATTERNS AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN SAUDI ARABIA
    Levy, A. R.
    Szabo, S. M.
    Osenenko, K. M.
    Korol, E. E.
    Qatami, L.
    Al Jaser, S.
    Al Saggabi, A.
    Al Suwaidan, S.
    Maclean, R.
    Donato, B. M. K.
    VALUE IN HEALTH, 2014, 17 (07) : A362 - A362
  • [27] Current practice in the management of patients with type 2 diabetes mellitus in Saudi Arabia
    Al-Elq, Abdulmohsen H.
    SAUDI MEDICAL JOURNAL, 2009, 30 (12) : 1551 - 1556
  • [28] Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus
    Bae, Jaehyun
    Kim, Youjin
    Cho, Yongin
    Lee, Minyoung
    Lee, Ji-Yeon
    Lee, Yong-ho
    Lee, Byung-Wan
    Cha, Bong-Soo
    Joo, Dong Jin
    Huh, Kyu Ha
    Kim, Myoung Soo
    Kim, Yu Seun
    Kang, Eun Seok
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (10) : 3444 - 3448
  • [29] Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study
    Williams, Rachael
    de Vries, Frank
    Kothny, Wolfgang
    Serban, Carmen
    Lopez-Leon, Sandra
    Chu, Changan
    Schlienger, Raymond
    DIABETES OBESITY & METABOLISM, 2017, 19 (10): : 1473 - 1478
  • [30] Meta-Analysis on the Effect and Safety of Dapagliflozin on Blood Sugar Fluctuation in Patients with Type 2 Diabetes Mellitus
    Chen, Shucheng
    Li, Tejun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (12): : 2600 - 2604
12345